复方血栓通胶囊联合羟苯磺酸钙治疗糖尿病视网膜病变疗效观察.docVIP

复方血栓通胶囊联合羟苯磺酸钙治疗糖尿病视网膜病变疗效观察.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
复方血栓通胶囊联合羟苯磺酸钙治疗糖尿病视网膜病变疗效观察

复方血栓通胶囊联合羟苯磺酸钙治疗糖尿病视网膜病变疗效观察   [摘要] 目的 探?复方血栓通胶囊联合羟苯磺酸钙治疗糖尿病视网膜病变的临床疗效。 方法 选取2016年1月~2017年1月我院住院治疗的糖尿病视网膜病变患者70例,根据治疗方法不同分为观察组35例、对照组35例。两组均予皮下注射胰岛素或口服降糖药治疗,控制患者空腹血糖7.0 mmol/L,餐后2 h血糖9.0 mmol/L。同时指导患者饮食,给予降压和降脂治疗。对照组予羟苯磺酸钙片口服,3粒/次,每天3次,观察组在对照组治疗的基础上联合复方血栓通胶囊口服,500 mg/次,每天3次,两组均连续治疗5个月。 结果 治疗后,观察组患者的临床总有效率明显高于对照组,两组疗效组间比较差异具有显著性(χ2=8.732,P0.05)。两组患者的视力及视野情况治疗后较治疗前均明显改善,其中与对照组治疗后比较,观察组患者的视力明显提高,视野MD值明显缩小,组间比较差异显著(P0.05)。 结论 复方血栓通胶囊联合羟苯磺酸钙治疗糖尿病视网膜病变效果确切,可使患者的视力明显提高,改善视功能,值得临床推广和应用。   [关键词] 糖尿病视网膜病变;复方血栓通胶囊;羟苯磺酸钙;视力;视野   [中图分类号] R587.2;R774.1 [文献标识码] A [文章编号] 1673-9701(2018)05-0030-03   [Abstract] Objective To investigate the clinical efficacy of compound Xueshuantong capsule combined with calcium dobesilate in the treatment of diabetic retinopathy. Methods Seventy patients with diabetic retinopathy hospitalized in our hospital from January 2016 to January 2017 were enrolled in this study. According to different treatment methods, the patients were divided into observation group(n=35) and control group(n=35). Both groups were subcutaneously injected with insulin or oral hypoglycemic agents to control the fasting blood glucose of patients7.0 mmol/L, and 2 h postprandial blood glucose 9.0 mmol/L. At the same time patients diet was guided and antihypertensive and lipid-lowering treatments were given. The control group was treated with calcium dobesilate orally, 3 capsules/time, 3 times a day. The observation group was treated with compound Xueshuantong capsule orally based on the treatment of the control group, with 500 mg/time daily, 3 times a day. The two groups were continuously treated for 5 months. Results After treatment, the total clinical efficiency of the observation group was significantly higher than that of the control group. There was significant difference in the efficiency between the two groups(χ2=8.732, P0.05). Visual acuity and visual field in both groups were significantly improved after treatment compared with before treatment. Compared with that o

您可能关注的文档

文档评论(0)

3471161553 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档